Amyris Stock

Amyris Debt/EBITDA

Delisted·May 7, 2024

The Total Debt to EBITDA Ratio of Amyris (AMRSQ) as of Aug 5, 2026 is -1.52. In the previous year, Total Debt to EBITDA Ratio was -2.36 — a change of -35.79% (higher).

Debt/EBITDA

-1.52

YoY

-35.79%

Last updated:

Total Debt to EBITDA Ratio of Amyris is 2026 -1.52 . Total Debt to EBITDA Ratio of Amyris was 2025 -2.36 . It decreases by -35.79% higher compared to the previous year.
Access this data via the Eulerpool API

Amyris Stock analysis

What does Amyris do? Amyris Inc. is a US-based company specializing in the production of sustainable products. It was founded in 2003 and is headquartered in Emeryville, California. The company aims to promote sustainability in daily life and reduce dependence on fossil fuels. Amyris' business model is based on the discovery and development of biological microorganisms capable of converting sugars and other carbohydrates into valuable products such as fuels, chemicals, and flavors. This technology, known as synthetic biology, was first used for the production of artemisinin, which is used against malaria. Over time, Amyris has expanded its portfolio and specialized in the production of sustainable products for the cosmetics, biofuel, food, and chemical industries. Leading products include Biosolve, an environmentally friendly degreasing solution for the industry, Neossance, a plant-based moisturizer for the cosmetics industry, and Biofene, a bio-based fuel. To produce its products, the company has formed partnerships with various organizations around the world. For example, it has partnered with Total, a French oil and gas company, to establish joint ventures for the production of biofuels. Amyris has also expanded its business by developing a platform for synthetic biology that allows other industry players to develop custom organisms for production processes. This new business model has brought the company into new markets such as the medical and energy sectors. In 2020, the COVID-19 pandemic posed challenges for the company as demand for some products declined. In response, Amyris shifted its production to disinfectants to meet the increased demand for these products. Overall, Amyris has become a leading company in sustainable production and is committed to promoting innovations in synthetic biology to have a positive impact on the environment. Amyris is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Amyris stock

Total Debt to EBITDA Ratio of Amyris is -1.52 in 2026.

Total Debt to EBITDA Ratio of Amyris changed from -2.36 to -1.52, representing a -35.79% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Amyris since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Amyris with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Amyris

All Key Metrics — Amyris